Regulatory

Blue California files patent for ergothioneine as support for oxidative stress related conditions

August 03, 2020

Blue California (Rancho Santa Margarita, CA) has filed a patent for the therapeutic uses of ergothioneine.

Probiotic taxonomy change has widespread industry impact

July 20, 2020

A taxonomy change for the Lactobacillus genus will impact probiotic product labels, product claims, GMPs, and more.

House Committee approves fiscal bill, includes FDA budget for CBD enforcement

July 15, 2020

The bill provides a funding increase of $5 million to protect the public from cannabis-derived products that are in violation of the Federal Food, Drug, and Cosmetic Act, as well as to create a potential regulatory pathway for cannabis-derived products.

FDA finds inconsistent levels of CBD, and THC presence, in hemp-derived CBD products

July 15, 2020

In its report to House and Senate Committees on Appropriations, FDA broke down the results of several years of sample studies the agency conducted on CBD products from 2014 to 2020.

Socati receives USDA organic certification for line of CBD ingredients

July 13, 2020

Socati Corp. (Austin, TX) received USDA organic certification for its CBD ingredient line for finished products.

New BAPP bulletin summarizes info on adulteration of English lavender oil

July 09, 2020

Although the safety and efficacy of authentic English lavender oil have been documented in published clinical trials, due to the comparatively high cost of English lavender essential oil, substitution with other, lower-cost species of Lavandula has been reported.